We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Biotechnology

Lycia Therapeutics

Aetna Wun Trombley

Nadia Tchao

Larry Rozsnyai

Patricia Chang

Winsome Chung

Matt Holdren

Darrin Lindhout

Steve Staben

The Research and Development team at Lycia Therapeutics is responsible for pioneering advancements in extracellular protein degradation through the LYTAC platform. This team orchestrates the discovery, development, and validation of innovative biologics and chemical entities, ensuring their progression from early research phases to translational and nonclinical development.

Research and Development

Scientific Research Team

Directors Team

Research and Development

About

Team members

Other teams at Lycia Therapeutics

Scientific Research Team

Directors Team